Nitroflurbiprofen is used as a nitric oxide (NO)-releasing cyclooxygenase (COX) inhibitor to improve portal hypertension in cirrhotic rats by reducing intrahepatic vascular resistance, ameliorating endothelial dysfunction, and decreasing hepatic hyperreactivity to vasoconstrictors, without causing major adverse effects.